UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Breast cancer research and treatment, 2021-09, Vol.189 (2), p.377-386

2021

Volltextzugriff (PDF)

Lymphoscintigraphy Can Select Breast Cancer Patients for Internal Mammary Chain Radiotherapy

International journal of radiation oncology, biology, physics, 2012-07, Vol.83 (4), p.1081-1088

2012

Volltextzugriff (PDF)

Nonpalpable breast lesions: impact of a second-opinion review at a breast unit on BI-RADS classification

European radiology, 2021-08, Vol.31 (8), p.5913-5923

2021

Volltextzugriff (PDF)

Distinct tumor protein p53 mutants in breast cancer subgroups

International journal of cancer, 2013-03, Vol.132 (5), p.1227-1231

2013

Volltextzugriff (PDF)

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

Oncogene, 2002-10, Vol.21 (49), p.7593-7597

2002

Volltextzugriff (PDF)

Intraoperative Radiotherapy for Breast Cancer in Elderly Women

Clinical breast cancer, 2022-01, Vol.22 (1), p.e109-e113

2022

Volltextzugriff (PDF)

NF-kappa B genes have a major role in inflammatory breast cancer

BMC cancer, 2008-02, Vol.8 (1), p.41-41, Article 41

2008

Volltextzugriff (PDF)

Concomitant medication, comorbidity and survival in patients with breast cancer

Nature communications, 2024-04, Vol.15 (1), p.2966-2966, Article 2966

2024

Volltextzugriff (PDF)

TP53 status and response to chemotherapy in breast cancer

Pathobiology (Basel), 2008-01, Vol.75 (2), p.132-139

2008

Volltextzugriff (PDF)

sup 18^F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

European journal of nuclear medicine and molecular imaging, 2016-05, Vol.43 (5), p.983

2016

Volltextzugriff (PDF)

Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients

European journal of nuclear medicine and molecular imaging, 2017-07, Vol.44 (7), p.1145-1154

2017

Volltextzugriff (PDF)

Non-genetic indications for risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

Gynécologie, obstétrique, fertilité & sénologie, 2022-02, Vol.50 (2), p.107

2022

Volltextzugriff (PDF)

Should FDG PET/CT be used for the initial staging of breast cancer?

European journal of nuclear medicine and molecular imaging, 2009-10, Vol.36 (10), p.1539-1542

2009

Volltextzugriff (PDF)

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different ^sup 18^F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

European journal of nuclear medicine and molecular imaging, 2015-10, Vol.42 (11), p.1682

2015

Volltextzugriff (PDF)

Indications des mastectomies de réduction de risque en dehors du risque avéré de prédisposition héréditaire : recommandations du Collège national des gynécologues et obstétriciens français (CNGOF)

Gynécologie Obstétrique Fertilité & Sénologie, 2022-02, Vol.50 (2), p.107-120

2022

Volltextzugriff (PDF)

Prognostic Impact of ^sup 18^FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer

JNCI : Journal of the National Cancer Institute, 2012-12, Vol.104 (24), p.1879

2012

Volltextzugriff (PDF)

Early monitoring of response to neoadjuvant chemotherapy in breast cancer with ^sup 18^F-FDG PET/CT: defining a clinical aim

European journal of nuclear medicine and molecular imaging, 2011-03, Vol.38 (3), p.419

2011

Volltextzugriff (PDF)

Agonistes de la GnRH en pathologie mammaire

Annales d'urologie, 2005-10, Vol.39, p.S59-S65

ESPIE, Marc

2005

Volltextzugriff (PDF)

Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study

European journal of cancer (1990), 2015-09, Vol.51 (13), p.1660-1666

2015

Volltextzugriff (PDF)

Correlation of high ^sup 18^F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer

European journal of nuclear medicine and molecular imaging, 2011-03, Vol.38 (3), p.426

2011

Volltextzugriff (PDF)

Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions

Annals of surgical oncology, 2021-04, Vol.28 (4), p.2138-2145

2021

Volltextzugriff (PDF)

Opérer ou non une lésion atypique du sein ? Prise en compte de l’anxiété dans l’aide à la décision partagée à partir d’une cohorte prospective de 300 patientes

Gynécologie Obstétrique Fertilité & Sénologie, 2022-02, Vol.50 (2), p.142-150

2022

Volltextzugriff (PDF)

Non-genetic indications for risk reducing mastectomies: Guidelines of the national college of French gynecologists and obstetricians (CNGOF)

Innovative Practice in Breast Health, 2024-03, Vol.1, p.100003, Article 100003

2024

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

ThemaMiddle Aged

ThemaBreast Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Lymphoscintigraphy Can Select Breast Cancer Patients for Internal Mammary Chain Radiotherapy

Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)

Nonpalpable breast lesions: impact of a second-opinion review at a breast unit on BI-RADS classification

Distinct tumor protein p53 mutants in breast cancer subgroups

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy

Intraoperative Radiotherapy for Breast Cancer in Elderly Women

NF-kappa B genes have a major role in inflammatory breast cancer

Concomitant medication, comorbidity and survival in patients with breast cancer

TP53 status and response to chemotherapy in breast cancer

sup 18^F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials

Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients

Non-genetic indications for risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

Should FDG PET/CT be used for the initial staging of breast cancer?

Do clinical, histological or immunohistochemical primary tumour characteristics translate into different ^sup 18^F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

Indications des mastectomies de réduction de risque en dehors du risque avéré de prédisposition héréditaire : recommandations du Collège national des gynécologues et obstétriciens français (CNGOF)

Prognostic Impact of ^sup 18^FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer

Early monitoring of response to neoadjuvant chemotherapy in breast cancer with ^sup 18^F-FDG PET/CT: defining a clinical aim

Agonistes de la GnRH en pathologie mammaire

Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III study

Correlation of high ^sup 18^F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer

Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions

Opérer ou non une lésion atypique du sein ? Prise en compte de l’anxiété dans l’aide à la décision partagée à partir d’une cohorte prospective de 300 patientes

Non-genetic indications for risk reducing mastectomies: Guidelines of the national college of French gynecologists and obstetricians (CNGOF)

Aktive Filter

Suchergebnisse filtern